Halozyme Therapeutics, Inc.
HALO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $444 | $282 | $202 | $403 |
| Dep. & Amort. | $89 | $85 | $57 | $7 |
| Deferred Tax | $0 | $35 | $0 | $0 |
| Stock-Based Comp. | $43 | $37 | $24 | $21 |
| Change in WC | -$136 | -$39 | -$110 | $3 |
| Other Non-Cash | $39 | -$10 | $67 | -$133 |
| Operating Cash Flow | $479 | $389 | $240 | $299 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$15 | -$5 | -$1 |
| Net Acquisitions | $0 | $0 | -$999 | $0 |
| Inv. Purchases | $0 | -$293 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $211 | $0 | $0 |
| Other Inv. Act. | -$252 | $0 | $517 | -$405 |
| Investing Cash Flow | -$263 | -$97 | -$487 | -$406 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$13 | $625 | $416 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$250 | -$402 | -$200 | -$350 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $31 | $8 | -$62 | $12 |
| Financing Cash Flow | -$219 | -$408 | $362 | $78 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | -$116 | $115 | -$29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $118 | $235 | $119 | $148 |
| End Cash | $116 | $118 | $235 | $119 |
| Free Cash Flow | $468 | $373 | $235 | $298 |